UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Stroke (1970), ISSN 0039-2499, 04/2009, Volume 40, Issue 4, pp. 1533 - 1538
Recombinant tissue plasminogen activator | Intraventricular hemorrhage | Thrombolysis | Intracerebral hemorrhage | Functional outcome | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular system | Neurology | Pharmacology. Drug treatments | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Vasodilator agents. Cerebral vasodilators | Cerebral Ventricles - physiology | Severity of Illness Index | Cerebral Hemorrhage - therapy | Animals | Cerebral Hemorrhage - physiopathology | Humans | Index Medicus
Journal Article
Stroke (1970), ISSN 0039-2499, 10/2011, Volume 42, Issue 10, pp. 2776 - 2781
urokinase-type plasminogen activator | intraventricular | ventriculostomy | meta-analysis | cerebral hemorrhage | fibrinolytic agents | tissue-type plasminogen activator | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Neurology | Neurotransmitters. Neurotransmission. Receptors | Pharmacology. Drug treatments | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Neuropharmacology | Serotoninergic system | Cerebral Hemorrhage - drug therapy | Cerebral Ventricles - surgery | Fibrinolytic Agents - therapeutic use | Humans | Injections, Intraventricular | Thrombolytic Therapy - methods | Cerebral Hemorrhage - surgery | Drainage - methods | Cerebral Hemorrhage - therapy | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Index Medicus
Journal Article
Stroke (1970), ISSN 0039-2499, 06/2012, Volume 43, Issue 6, pp. 1666 - 1668
intraventricular hemorrhage | thrombolysis | randomized controlled trials | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Neurology | Biological and medical sciences | Muscle | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Pharmacology. Drug treatments | Cerebral Hemorrhage - drug therapy | Lateral Ventricles - pathology | Humans | Middle Aged | Proportional Hazards Models | Male | Tissue Plasminogen Activator - administration & dosage | Cerebral Hemorrhage - physiopathology | Dose-Response Relationship, Drug | Time Factors | Adolescent | Thrombolytic Therapy - methods | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Lateral Ventricles - physiopathology | Cerebral Hemorrhage - pathology | Index Medicus
Journal Article
Stroke (1970), ISSN 0039-2499, 11/2011, Volume 42, Issue 11, pp. 3009 - 3016
intracerebral hemorrhage | thrombolysis | intraventricular hemorrhage | tissue-type plasminogen activator | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Neurology | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Cerebral Hemorrhage - drug therapy | Thrombosis - physiopathology | Respiration Disorders - chemically induced | Humans | Middle Aged | Male | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Recombinant Proteins - adverse effects | Cerebral Hemorrhage - physiopathology | Recombinant Proteins - administration & dosage | Tissue Plasminogen Activator - adverse effects | Up-Regulation - physiology | Thrombolytic Therapy - methods | Placebos | Female | Thrombosis - drug therapy | Blood Coagulation - physiology | Cohort Studies | Index Medicus
Journal Article
Stroke (1970), ISSN 0039-2499, 09/2014, Volume 45, Issue 9, pp. 2629 - 2635
mortality | thrombolytic therapy | cerebral hemorrhage | ventriculostomy | cerebrospinal fluid shunt | meningitis | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Neurology | Biological and medical sciences | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Length of Stay | Comorbidity | Humans | Middle Aged | Male | Treatment Outcome | Hospitalization | Tissue Plasminogen Activator - therapeutic use | Cerebral Hemorrhage - physiopathology | Health Care Costs | Algorithms | Thrombolytic Therapy - methods | Cerebral Hemorrhage - therapy | Female | Aged | Ventriculostomy - methods | Odds Ratio | Cohort Studies | Index Medicus | intracerebral hemorrhage | real-world | intraventricular thrombolysis | intraventricular hemorrhage | outcomes | shunting | thrombolysis | hemorrhagic stroke | nationwide inpatient sample
Journal Article
Stroke (1970), ISSN 0039-2499, 09/2014, Volume 45, Issue 9, pp. 2662 - 2669
fibrinolysis | meta-analysis | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Neurology | Pharmacology. Drug treatments | Biological and medical sciences | Neuroprotective agent | Vascular diseases and vascular malformations of the nervous system | Medical sciences | Neuropharmacology | Recurrence | Humans | Thrombolytic Therapy - methods | Cerebral Hemorrhage - mortality | Cerebral Hemorrhage - therapy | Risk | Treatment Outcome | Clinical Trials as Topic | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10069, pp. 603 - 611
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Stroke - diagnostic imaging | Humans | Middle Aged | Proportional Hazards Models | Male | Tomography, X-Ray Computed | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Sodium Chloride - therapeutic use | Cerebral Intraventricular Hemorrhage - therapy | Cerebral Intraventricular Hemorrhage - diagnostic imaging | Therapeutic Irrigation - methods | Fibrinolytic Agents - therapeutic use | Drainage - methods | Female | Aged | Stroke - therapy | Stroke (Disease) | Clinical trials | United Kingdom | Nervous system diseases | Drug therapy | Mortality | Care and treatment | Analysis | Jefferson, Thomas (American president) | Intensive care | Stroke | Patients | Hemorrhage | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2014, Volume 85, pp. 158 - 165
Animal model | Cerebral hemorrhage | Ventriculostomy | Tissue-type plasminogen activator | Fibrinolytic agents | Intraventricular | Urokinase-type plasminogen activator | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Fibrinolysis - drug effects | Recovery of Function - drug effects | Hydrocephalus - pathology | Male | Neuroimmunomodulation - physiology | Cerebral Hemorrhage - physiopathology | Hydrocephalus - physiopathology | Hematoma - drug therapy | Disease Models, Animal | Cerebral Hemorrhage - drug therapy | Brain - physiopathology | Brain Edema - pathology | Cells, Cultured | Hydrocephalus - drug therapy | Random Allocation | Rats, Sprague-Dawley | Brain - drug effects | Collagenases | Fibrinolytic Agents - pharmacology | Animals | Tissue Plasminogen Activator - pharmacology | Brain Edema - physiopathology | Hematoma - pathology | Brain - pathology | Brain Edema - drug therapy | Hematoma - physiopathology | Mice | Cerebral Hemorrhage - pathology | Urokinase-Type Plasminogen Activator - pharmacology | Neuroimmunomodulation - drug effects | Urokinase | Intraventricular hemorrhage | Tissue plasminogen activator | Proteases | Analysis | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 10/2017, Volume 89, Issue 15, pp. 1553 - 1560
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cerebral Ventricles - pathology | Leukocytes - pathology | Cerebral Hemorrhage - drug therapy | Tomography Scanners, X-Ray Computed | Humans | Erythrocytes | Male | Cerebral Hemorrhage - diagnostic imaging | Cytokines - cerebrospinal fluid | Cerebral Hemorrhage - cerebrospinal fluid | Time Factors | Fibrinolytic Agents - therapeutic use | Glucose - metabolism | Female | Leukocyte Count | Cerebral Hemorrhage - pathology | Index Medicus | Abridged Index Medicus | 23 | 7
Journal Article
Annals of neurology, ISSN 0364-5134, 11/2020, Volume 88, Issue 5, pp. 1050 - 1051
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Diagnosis, Differential | Cerebral Ventricles - diagnostic imaging | Humans | Middle Aged | Silicone Oils - adverse effects | Female | Tomography, X-Ray Computed | Retinal Detachment - drug therapy | Cerebral Hemorrhage - diagnostic imaging | Silicone Oils - therapeutic use | Cerebral Hemorrhage - diagnosis | Retinal Detachment - complications | Silicones | Hemorrhage | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 03/2015, Volume 84, Issue 10, pp. 989 - 994
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cerebral Ventricles - pathology | Follow-Up Studies | Humans | Middle Aged | Hematoma - diagnostic imaging | Cerebral Hemorrhage - mortality | Hematoma - mortality | Male | Treatment Outcome | Cerebral Hemorrhage - diagnostic imaging | Disease Progression | Radiography | Time Factors | Aged, 80 and over | Cerebral Hemorrhage - therapy | Female | Aged | Index Medicus | Abridged Index Medicus | 119 | 112 | 295
Journal Article